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Comparison of Transjugular Intrahepatic Portosystemic 
Shunt with Covered Stent and Balloon-Occluded 
Retrograde Transvenous Obliteration in Managing 
Isolated Gastric Varices
Seung Kwon Kim, MD1, 3, Kristen A. Lee, MD1, Steven Sauk, MD1, Kevin Korenblat, MD2
1Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University St. Louis School of Medicine, St. Louis, MO 63110, USA; 
2Division of Gastroenterology, Department of Internal Medicine, Washington University St. Louis School of Medicine, St. Louis, MO 63110, USA; 
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Objective: Although a transjugular intrahepatic portosystemic shunt (TIPS) is commonly placed to manage isolated gastric 
varices, balloon-occluded retrograde transvenous obliteration (BRTO) has also been used. We compare the long-term 
outcomes from these procedures based on our institutional experience.
Materials and Methods: We conducted a retrospective review of patients with isolated gastric varices who underwent either 
TIPS with a covered stent or BRTO between January 2000 and July 2013. We identified 52 consecutive patients, 27 who had 
received TIPS with a covered stent and 25 who had received BRTO. We compared procedural complications, re-bleeding 
rates, and clinical outcomes between the two groups.
Results: There were no significant differences in procedural complications between patients who underwent TIPS (7%) and 
those who underwent BRTO (12%) (p = 0.57). There were also no statistically significant differences in re-bleeding rates 
from gastric varices between the two groups (TIPS, 7% [2/27]; BRTO, 8% [2/25]; p = 0.94) or in developing new ascites 
following either procedure (TIPS, 4%; BRTO, 4%; p = 0.96); significantly more patients who underwent TIPS developed 
hepatic encephalopathy (22%) than did those who underwent BRTO (0%, p = 0.01). There was no statistically significant 
difference in mean survival between the two groups (TIPS, 30 months; BRTO, 24 months; p = 0.16); median survival for the 
patients who received TIPS was 16.6 months, and for those who underwent BRTO, it was 26.6 months.
Conclusion: BRTO is an effective method of treating isolated gastric varices with similar outcomes and complication rates 
to those of TIPS with a covered stent but with a lower rate of hepatic encephalopathy.
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INTRODUCTION
Variceal bleeding from either esophageal or gastric 
varices is a serious complication in patients with portal 
hypertension. Although they are less prevalent and 
less prone to bleeding than esophageal varices, gastric 
varices are notoriously difficult to treat, often requiring 
more transfusions; they are also associated with higher 
mortality, up to 55% (1). Currently, treatment options 
include medical, surgical, endoscopic, and endovascular 
approaches, with endoscopic variceal sclerotherapy the 
first line of treatment. However, due to the large size and 
location of isolated gastric varices, long-term success in 
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and delayed complications and clinical, endoscopic and 
imaging follow-up.
During the period of January 2000 through July 2013, 
a total of 253 patients received TIPS for bleeding from 
gastric, esophageal and/or rectal varices, of whom 27 
patients with isolated gastric varices were treated with TIPS 
using covered stents. Of these 27 patients, 26 had active 
bleeding or recent history of gastric variceal bleeding, and 
one had been treated with TIPS preoperatively prior to 
rectal surgery. Supplemental embolization of gastric varices 
with multiple coils had been performed in 10 of 27 patients 
(37%) when there was persistent filling of gastric varices 
after TIPS placement.
Beginning in November 2009 and through July 2013, 25 
patients with isolated gastric varices underwent BRTO. Of 
these 25 patients, 20 had active bleeding or recent history 
of gastric variceal bleeding, and five had been treated for 
prophylaxis. Sixteen of the 25 patients (57%) had had 
supplemental collateral veins treated with procedures such 
as inferior phrenic vein embolization.
The baseline characteristics of both groups of patients 
are summarized in Table 1. There was no difference in 
age between the TIPS and BRTO patients in regards to 
age; the average age of the TIPS patients was 58 (range: 
34–81 years), and that of the BRTO patients was 59 (range: 
26–86 years). However, more women (16) had received 
BRTO than TIPS (8; p < 0.05). There were no differences 
in the etiologies of the gastric varices, the pre-treatment 
Model for End-Stage Liver Disease (MELD) scores, or portal 
hypertension complications, namely, hepatic encephalopathy 
and ascites (p > 0.05).
TIPS
The TIPS procedure had been performed under moderate 
sedation or general anesthesia according to the patient’s 
condition, and prophylactic antibiotics were administered 
to all patients. The hepatic vein was accessed from a 
right internal jugular approach, and wedged hepatic 
venography was performed to localize the portal vein. The 
portal vein was then accessed using a Colapinto needle 
(Cook Inc., Bloomington, IN, USA) passed from the right 
or middle hepatic vein. Pressures were measured in the 
right atrium and the portal vein to determine a pre-
TIPS portosystemic gradient, and portal venograms were 
obtained. The parenchymal tract was then pre-dilated and 
then dilated using an 8–10 mm angioplasty balloon, and 
a 10-mm covered stent (Viatorr [n = 24], W. L. Gore and 
managing them endoscopically is limited (2-3). Transjugular 
intrahepatic portosystemic shunt (TIPS) is also widely used 
in managing gastric varices, but high-level evidence of its 
benefits is lacking, and diverting portal blood flow can 
further compromise liver function and aggravate hepatic 
encephalopathy (4-6).
A number of studies have demonstrated balloon-occluded 
retrograde transvenous obliteration (BRTO) as an effective 
treatment method for isolated gastric varices, which are 
often associated with spontaneous gastrorenal shunts (7). 
By occluding portosystemic shunts, BRTO is thought to 
improve liver function by increasing portal venous blood 
flow; however, the increased portal pressure may increase 
the risk of esophageal variceal bleeding, worsening ascites 
and portal hypertensive gastropathy (8).
To date, only three studies directly compare the efficacy 
and outcomes of TIPS and BRTO (9-11), and only one study 
has evaluated the efficacy and outcomes of treating gastric 
varices using TIPS with a covered stent. TIPS created with 
bare metal stents are known to have lower patency rates 
compared with covered stents and likely account for the 
higher re-bleeding rates from TIPS procedures that were 
found in previous studies (9, 10, 12-14).
Therefore, we here present a retrospective study 
comparing the long-term outcomes of TIPS with covered 




The Institutional Review Board approved this retrospective 
study, and informed consent was waived. We performed a 
retrospective cohort comparison of 52 consecutive patients 
from our institution with bleeding gastric varices who were 
treated with either TIPS using a covered stent or with BRTO. 
Specifically, isolated gastric varices (Type 1 and 2) were 
treated based on the Sarin classification (15). We searched 
the Radiology Information Systems database for patients 
who had undergone either TIPS or BRTO during the period 
of January 2000 through July 2013. Before 2009, TIPS was 
performed to manage isolated gastric varices. Since we 
began using BRTO in 2009, the choice of TIPS vs. BRTO has 
been based on the operator’s preference.
We reviewed electronic medical records for patient 
demographics, pre-procedural clinical data, intra-procedural 
information, and post-procedural data including immediate 
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Associates Inc., Flagstaff, AZ, USA; Flucency [n = 2], Bard 
Peripheral Vascular, Tempe, AZ, USA; Viabahn [n = 1], W. L. 
Gore and Associates Inc.) was placed. After the TIPS was 
created, portal venography was performed with the catheter 
positioned in the splenic vein to assess for filling of any 
gastric varices; the varices were embolized if persistent 
filling was noted. A final mean portosystemic gradient 
was measured and optimized to be < 12 mm Hg. Technical 
success for each TIPS procedure was defined per the Society 
of Interventional Radiology reporting standards as the 
creation of a patent TIPS between the hepatic vein and a 
branch of the portal vein (16).
BRTO Procedure
The BRTO procedure was performed under moderate 
sedation via the transfemoral or transjugular approach 
following placement of a 9–10 French sheath based on 
the size and anatomy of the gastrorenal shunt; this shunt 
was selected and catheterized via the left renal vein, with 
occlusion balloon catheters such as a 6 Fr wedge pressure 
catheter (Teleflex Medical, Arrow International Inc., Wayne, 
PA, USA) or a 6 Fr Berenstein occlusion balloon catheter 
(Boston Scientific, Natick, MA, USA) advanced to the 
shunt coaxially over the stiff guide wire. Balloon-occluded 
retrograde venography was performed to evaluate the 
anatomy of the shunt and varices. After embolization of 
any collateral veins including the inferior phrenic vein with 
a 2.7 Fr microcatheter (Progreat; Terumo Medical, Elkron, 
MD, USA) and 3–6 mm microcoils (Nester Coil; Cook Inc.). 
With the occlusion balloon inflated, the sclerosant was 
administered to fill the varices under fluoroscopic guidance. 
Ethanolamine oleate (16–20 cc) mixed with Lipiodol 
(Ethiodol; Savage Laboratories, Melville, NY, USA) was used 
as the sclerosant for the initial four patients, and 8–16 
cc sodium tetradecol sulfate (Sotradecol; AngioDynamics, 
Queensbury, NY, USA) mixed with Lipiodol and air (2:1:3 
ratio) was used as the sclerosant for the remaining patients. 
The occlusion balloon remained inflated post procedure for 
4–20 hours (mean inflation time: 13 hours) according to the 
timing of the procedure and was removed after stagnation 
of the sclerosant was confirmed on follow-up abdominal 
radiography. Technical success for the BRTO procedure was 
defined as successful placement of the occlusion balloon in 
the gastrorenal shunt and administration of the sclerosant 
mixture into the varices.
Table 1. Baseline Characteristics for Patients Who Underwent TIPS vs. BRTO for Isolated Gastric Varices
  TIPS (n = 27) BRTO (n = 25) P
Demographics
Male 19 9 < 0.05
Mean age (years)† 58 (13) 59 (2.5)
Gastric varices etiology‡
Alcohol 14 6
Viral hepatitis (B and/or C) 10 9
NASH 4 2
Cryptogenic 2 4
Portal vein/splenic vein thrombosis 1 1
Primary biliary cirrhosis 0 1
Autoimmune hepatitis 0 1
Medication related cirrhosis* 0 1
Pre-procedure†
Ascites 5 7 0.27
Hepatic encephalopathy 1 1 0.27
Total bilirubin (mg/dL) 2.2 (1.4) 3.5 (7.2) 0.19
INR 1.5 (0.3) 1.4 (0.3) 0.95
Creatinine (mg/dL) 0.8 (0.3) 0.9 (0.3) 0.55
MELD score 13 (3.6) 14 (4.9) 0.21
*Patient with hepatic C status post liver transplant and was thought to have drug related cirrhosis of allograft, †Numbers in parentheses 
represent standard deviation, ‡Some patients had multiple etiologies (i.e., hepatitis C + alcohol). BRTO = balloon-occluded retrograde 
transvenous obliteration, INR = international normalized ratio, MELD = Model for End-Stage Liver Disease, NASH = nonalcoholic 
steatohepatitis, TIPS = transjugular intrahepatic portosystemic shunts
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Endoscopy and Imaging Follow-Up
The patients were followed with endoscopy every 3–6 
months following the BRTO procedure. All patients who 
presented with re-bleeding underwent endoscopy to 
determine the source of the bleeding.
Doppler ultrasonography (US) was performed at 1, 3, 6, 
and 12 months following TIPS placement and every 6–12 
months thereafter unless there was intervening clinical 
deterioration.
Computed tomography (CT) or magnetic resonance (MR) 
imaging was performed at 3–6 months following each BRTO 
procedure to confirm variceal obliteration.
Analysis
Early re-bleeding was defined as recurrent bleeding within 
seven days following the TIPS or BRTO procedure, and late 
re-bleeding was defined as recurrent bleeding after seven 
days following the procedure. Hepatic encephalopathy was 
defined and the degree characterized based on the West 
Haven Criteria for quantitative grading of mental state in 
hepatic encephalopathy (17).
We used the chi-squared test and Fisher’s exact test to 
compare differences in baseline characteristics, the rates 
of complications, re-bleeding, new hepatic encephalopathy, 
new ascites, repeat intervention, and resolution of gastric 
varices on follow-up endoscopies, and a p value of < 0.05 
was considered statistically significant. We calculated 
survival using the Kaplan-Meier estimator and performed all 




Technical success was achieved in 100% of the patients 
who received a TIPS (27 of 27) and 88% of the patients 
who underwent BRTO (22 of 25); the BRTO failures were 
balloon ruptures (n = 2) and a right common femoral artery 
injury (n = 1). As noted before, ten of the 27 TIPS patients 
underwent supplemental gastric varices embolization with 
multiple coils. The mean portosystemic gradients pre-TIPS 
and post-TIPS measured 15 ± 5.4 mm Hg and 6 ± 3.3 mm 
Hg, respectively, with a mean decrease of 9 ± 5.7 mm Hg in 
the portosystemic gradient following TIPS.
Procedural Complications
There were no statistically significant differences in 
procedural complications between the TIPS and BRTO 
groups (p = 0.57) (Table 2). Within the TIPS group, one 
patient had an episode of oxygen desaturation that required 
bag ventilation and administration of naloxone to return 
to baseline. Another patient had a 5 mm coil placed for 
variceal embolization that migrated to the left lower lobe 
pulmonary artery but remained asymptomatic. In the BRTO 
group, two patients experienced balloon rupture within six 
hours of inflation, and one of these patients underwent 
Table 2. Comparing Outcomes of TIPS vs. BRTO for Isolated Gastric Varices
  TIPS (n = 27) BRTO (n = 25) P
Procedural complications
Yes 2 3 0.57
Post procedure labs*
Mean # days after procedure 64 (262) 88 (117) 0.68
Total bilirubin (mg/dL) 2.1 (1.4) 3.7 (9.5) 0.46
INR 1.5 (0.1) 1.5 (0.4) 0.98
Serum creatinine (mg/dL) 0.8 (0.3) 1.0 (0.5) 0.11
MELD score 13 (3.3) 13 (6.4) 0.97
Change in MELD score +1 (0.9) 0 (3.6) 0.21
Clinical outcomes
New hepatic encephalopathy 6 0 0.01
New ascites 1 1 0.96
Rebleeding 3 3 0.92
Rebleeding from GV source 2 2 0.94
Mean follow-up (days)* 917 (908) 727 (533) 0.03
*Numbers in parentheses represent standard deviation. BRTO = balloon-occluded retrograde transvenous obliteration, GV = gastric varices, 
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TIPS due to presumed gastric variceal bleeding one day 
later. Another patient sustained a common femoral artery 
injury during the process of acquiring femoral venous 
access, and this required an open arteriotomy repair. It was 
not possible to leave the occlusion balloon and sheath, and 
therefore, the gastrorenal shunt was embolized with coils 
to retain the sclerosant in the varix before the balloon was 
deflated and the sheath removed; this patient underwent 
TIPS due to presumed gastric variceal bleeding two days 
later (Fig. 1).
Outcomes
There were no differences in immediate post-procedure 
laboratory values (total bilirubin, INR, serum creatinine) 
and MELD scores during the follow-up period (TIPS: mean, 
64 days vs. BRTO: mean, 88 days; p > 0.05) (Table 2).
There was a significantly higher rate of hepatic 
encephalopathy within the TIPS group (6 of 27 patients; 
22%) than in the BRTO group (0 of 25 patients; 0%, p = 
0.01) (Table 2). Among the six patients who were treated 
for hepatic encephalopathy in the TIPS group, five were 
documented as having trivial lack of awareness (grade 1), 
and one was noted to have mild disorientation to time and 
place (grade 2). All patients demonstrated improvement 
upon discharge.
There was no statistically significant difference in 
development of new ascites following TIPS (4%) or BRTO 
(4%, p = 0.96) (Table 2). There was also no statistically 
significant difference in re-bleeding rates from gastric 
varices between the TIPS (2/27, 7%) and BRTO groups (2/25, 
8%; p = 0.94) (Table 2). Figure 2 illustrates re-bleeding 
after TIPS or BRTO in 52 patients. Among the TIPS group, 
three patients (3/27, 11%) presented with early and late 
re-bleeding (gastric varices: n = 2; gastric ulcer: n = 1). 
One patient developed hematemesis two days following 
TIPS placement from gastric varices, which was successfully 
treated with coil embolization. Two additional patients 
presented with hematemesis: one case was 18 months 
following TIPS, from an oozing gastric ulcer–although 
no varices were seen–and was successfully treated with 
epinephrine injection, and the other, two years following 
TIPS, was re-bleeding from gastric varices that was treated 
with TIPS revision due to stenosis (Fig. 3).
Among the BRTO group, three patients (12%) presented 
with early and late re-bleeding (gastric varices: n = 2; 
esophageal varices: n = 1). One patient who had a balloon 
rupture within six hours presented with hematemesis one 
day following the procedure from presumed gastric variceal 
bleeding and was treated with TIPS and coil embolization 
of the gastric varices. A second patient with right femoral 
artery injury presented with hematemesis from presumed 
gastric variceal bleeding two days following the procedure 
and was treated with TIPS (Fig. 1). One patient presented 
with hematemesis nine months later from esophageal 
variceal bleeding, which was subsequently treated with 
endoscopic band ligation.
The mean survival for the patients who received TIPS was 
30 months, and for those who underwent BRTO, it was 24 
months; there was no statistically significant difference 
between the two groups (p = 0.16). The median survival for 
the patients who received TIPS was 16.6 months, and for 
those who underwent BRTO, it was 26.6 months.
Endoscopy and Imaging Follow-Up
Significantly more patients who underwent BRTO received 
follow-up endoscopy, and of these, the gastric varices were 
resolved in 87% of the patients who underwent BRTO (13 of 
15) and in 60% of those who received TIPS (3 of 5) (Table 
2). However, these differences did not approach statistical 
significance. One TIPS patient demonstrated persistent 
gastric varices at three-month follow-up endoscopy; 
because of the increased risk of bleeding, the patient 
subsequently underwent TIPS revision. Among the BRTO 
group, one patient presented with persistent gastric varices, 
which decreased in size on nine-month follow-up endoscopy 
and remained asymptomatic and thus did not require any 
intervention. Another patient presented with recurrent 
gastric varices 3.5 years following the BRTO procedure 
with no bleeding episodes and thus did not require further 
intervention.
Two patients in the TIPS group underwent TIPS revision 
due to US Doppler findings suggesting shunt stenosis. 
Fifteen patients in the BRTO group underwent follow-up CT 
or MR imaging during follow-up that demonstrated complete 
obliteration of the gastric varices in all patients.
DISCUSSION
Variceal bleeding remains a serious complication of portal 
hypertension. Although treatment of esophageal varices 
is well established with endoscopic methods, the long-
term success of gastric varices is limited in part due to the 
high flows through the varix and also the location of the 
varices in the cardia/gastric fundus (18). In addition, due 
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to their size, sclerosis of the gastric varices often requires 
larger volumes of sclerosant and poses a higher risk of 
pulmonary system embolization (19). TIPS has been widely 
used for decades to manage gastric varices, and BRTO has 
emerged as an alternative treatment method, specifically 





Fig. 1. 68-year-old woman with nonalcoholic steatohepatitis cirrhosis and recurrent gastric variceal bleeding. 
A. Balloon-occluded venogram of gastro-renal shunt shows contrast filling of gastric varices (arrows) along with draining inferior phrenic 
collateral vein (open arrow). B. Inferior phrenic vein was embolized with microcoils (open arrow). This was followed by injection of sodium 
tetradecyl sulfate (Sotradecol; AngioDynamics) mixed with Lipiodol into gastric varices (arrows). C. It was not possible to leave occlusion balloon 
and sheath due to common femoral artery injury while obtaining femoral venous access. Therefore, gastrorenal shunt was embolized with multiple 
coils (open arrow) to retain sclerosant (arrows) in gastric varices before balloon was deflated and sheath was removed. D. Patient presented 
with hematemesis two days following procedure. TIPS was performed due to presumed gastric variceal bleeding. Venogram after TIPS placement 
showed no gastric varix filling from afferent veins and dense Lipiodol uptake (arrows) in gastric varices. Portosystemic gradient decreased from 
15 mm Hg to 5 mm Hg. TIPS = transjugular intrahepatic portosystemic shunts
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contraindicated (20).
Limited intra-institutional studies have compared the 
outcomes of TIPS and BRTO in managing gastric varices 
(9, 10, 11). In a study by Choi et al. (9), patients with 
active gastric variceal bleeding due to liver cirrhosis were 
treated with either TIPS (n = 13) or BRTO (n = 8), and no 
statistically significant differences were noted in either 
immediate hemostasis or re-bleeding (9). A larger study 
by Ninoi et al. (10) evaluated 104 patients, 27 of whom 
were treated with TIPS and 77 of whom were treated with 
transcatheter sclerotherapy. The cumulative gastric variceal 
bleeding rates at one year were significantly better in the 
BRTO group (TIPS: 20% vs. BRTO: 2%). Furthermore, survival 
rates at 1, 3, and 5 years following BRTO were better than 
those after TIPS. However, the improved survival was only 
statistically significant for patients classified as Child-Pugh 
class A (as opposed to class B or C) prior to treatment. It 
is important to note that the TIPS procedures in that study 
used bare metal stents, which are known to have lower 
patency than covered stents and which likely accounted 
for the higher re-bleeding rates (21). More recently, Sabri 
et al. (11) demonstrated equivalent short-term re-bleeding 
for isolated gastric varices managed by TIPS with covered 
stents (11%) and BRTO (0%, p = 0.25). Similar to the 
results reported by Sabri et al. (11), our study demonstrated 
no significant difference in gastric varix re-bleeding 
between the two groups (p = 0.94).
In the TIPS group, three patients (3/27, 11%) presented 
with early and late re-bleeding (gastric varices: n = 2; 
gastric ulcer: n = 1). The two patients who had re-bleeding 
from their gastric varices were subsequently treated with 
coil embolization of the varices and TIPS revision due to 
stenosis (Fig. 3).
In the BRTO group, three patients (12%) presented with 
early and late re-bleeding (gastric varices: n = 2; esophageal 
varix: n = 1). Two patients presented with presumed gastric 
variceal bleeding within two days following the procedure, 
and they were subsequently treated with TIPS placement. 
These early re-bleeding cases were mostly the result of 
inadequate sclerosis of the gastric varices. In one patient, 
there was balloon rupture within six hours, and in the 
other, the balloon was deflated after injection of sclerosant 
and coil embolization of gastrorenal shunts due to right 
common femoral artery injury (Fig. 1).
Because most fundal gastric varices drain into the left 
renal vein via a spontaneous gastrorenal shunt, obliterating 
Fig. 2. Flowchart summarizing re-bleeding after TIPS or BRTO in 52 patients. BRTO = balloon-occluded retrograde transvenous 
obliteration, GV = gastric varices, TIPS = transjugular intrahepatic portosystemic shunts
TIPS (n = 27)
Rebleeding (n = 3) Rebleeding (n = 3)
Early rebleeding from GV (n = 1)
–treat with coil embolization
Early rebleeding from GV (n = 1)
–treated with TIPS
Balloon rupture (n =1)
Right femoral artery injury (n = 1)
Late rebleeding (n = 1)
Gastric ulcer–treat with epinephrine injection
Rebleeding from GV–treat with TIPS revision
Late rebleeding (n = 1)
Esophageal variceal bleeding
–treat with endoscopic band ligation
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the gastric varices excludes the shunt from portosystemic 
circulation (1-3), and occluding portosystemic shunts 
in BRTO leads to significant changes in portal hepatic 
hemodynamics (22). Although transient improvement in 
hepatic function has been reported with increased portal 
hepatic blood flow, symptoms associated with portal 
hypertension can be further exacerbated post treatment 





Fig. 3. 47-year-old man with alcoholic liver cirrhosis with acute gastric variceal bleeding. 
A. TIPS procedure was performed using 10 x 50 mm Viatorr stent (arrows) and 10 x 68 mm Wallstent (open arrows) extending to hepaticocaval 
junction. Portosystemic gradient decreased from 20 mm Hg to 8 mm Hg. Patient presented with recurrent gastric variceal bleeding two years 
later. B. TIPS venogram showed tight stenosis (arrows) at TIPS stent near hepaticocaval junction. C. Balloon angioplasty was performed at tight 
stenosis (arrows) near hepaticocaval junction. D. TIPS venogram after balloon angioplasty showed interval improvement of stenosis (arrows). 
Portosystemic gradient decreased from 15 mm Hg to 5 mm Hg. TIPS = transjugular intrahepatic portosystemic shunts
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One of the most important reported complications 
associated with BRTO is aggravated esophageal varices (8, 
22); reported rates of worsening esophageal varices vary 
up to 63%, with 11–24% subsequent variceal bleeding 
(23, 24). The wide range of reported rates is thought to 
be related to the variations in patient populations and the 
causes and severity of liver disease, as well as the different 
follow-up durations (8). In our present study, only one 
patient in the BRTO group presented, nine months following 
the procedure, with esophageal variceal bleeding, which was 
successfully treated with endoscopic band ligation. The rate 
of esophageal variceal bleeding in our study was relatively 
lower than that reported in the literature, which may in 
part have been due to the shorter follow-up duration.
A substantive risk from TIPS is that of severe 
encephalopathy, with incidence estimates as high as 20%. 
A potential benefit of BRTO is that it avoids this risk 
by diverting blood flow (25). In this study, none of the 
patients developed encephalopathy in the BRTO group, 
whereas six developed new encephalopathy following TIPS 
placement.
In our study, the mean pre-TIPS portosystemic gradient 
of 15 mm Hg was unusually low. In the study by Chao et al. 
(26), the mean hepatic venous pressure gradient was 11.2 
mm Hg for gastric varices and 15.5 mm Hg for esophageal 
varices. Thus, diminished portal pressure (< 12 mm Hg) is 
more likely in patients with gastric varices.
It is difficult to compare the costs between the two 
groups including devices, procedure time, follow-up, etc. 
BRTO does require post-procedure dwell times for vascular 
sheaths in observation or intensive care units in our 
hospital; thus, it may be less cost-effective than TIPS 
unless the patient is already in intensive care.
This study has a number of limitations. First, it is 
retrospective nature and used a relatively small number of 
patients. Furthermore, the retrospective nature of the study 
limits the ability to evaluate for delayed complications 
such as hepatic encephalopathy and development of post-
procedure ascites. Significantly more patients in the BRTO 
group (15 of 25; 60%) received follow-up endoscopies 
than in the TIPS group (5 of 27; 19%), although the mean 
follow-up for TIPS patients is significantly longer than that 
for BRTO patients. This is likely secondary to the fact that 
patients who undergo TIPS are more likely to be followed 
for signs of bleeding as opposed to routine endoscopy.
Second, there was selection bias in the choice of TIPS vs. 
BRTO with no selection criteria for the choice. Before 2009, 
TIPS was performed to manage isolated gastric varices, but 
since we began BRTO in 2009, the choice of management 
technique was based on operator preference.
In conclusion, BRTO is an effective method of treating 
isolated gastric varices with similar outcomes and 
complication rates as TIPS with a covered stent but lower 
rates of hepatic encephalopathy. Multi-center prospective 
randomized studies are needed to determine the long-term 
outcomes in order to develop tailored treatment strategies 
for individual patients who present with isolated gastric 
variceal bleeding.
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